Performance and survival of transvenous defibrillation leads: Need for a European data registry

Europace

Volumn 11, Issue 1, 2009, Pages 31-34

  Goette, Andreas ^a   Cantu, Francesco ^b   Van Erven, Lieselot ^c   Geelen, Peter ^d   Halimi, Franck ^e   Merino, Jose L ^f   Morgan, John M ^g  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b Cardiovasular Department   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OLV HOSPITAL   (Belgium)

^e Cardiac Pacing and Rhythmology Department   (France)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Defibrillator; Failure; Inappropriate shocks; Lead; Registry

Indexed keywords

CARDIOVERSION; CONDUCTOR; DEFIBRILLATION; DEFIBRILLATOR; DISEASE REGISTRY; EUROPE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVIEW;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; EUROPE; HUMANS; ITALY; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES;

EID: 58149086015     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun301     Document Type: Review

References (41)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
2. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-80.
3. Ding L, Hua W, Niu H, Chen K, Zhang S. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 2008;10:1034-41.
4. Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA et al. for the SCD-HeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006;114:135-42.
5. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. MADIT-II Investigators. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96.
6. Klein H, Auricchio A, Reek S, Geller C. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999;83:91D-7D.
7. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-18.
8. Maisel WH. Pacemaker and ICD generator reliability. Meta-analysis of device registries. JAMA 2006;295:1929-34.
9. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB et al. Pacemaker and ICD generator malfunction. Analysis of food and drug administration annual reports. JAMA 2006;295:1901-6.
10. Farwell D, Redpath C, Birnie D, Gollob M, Lemery R, Posan E et al. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with appropriate interrogation. Europace 2008;10:726-8.
11. Maisel WH, Kramer DB. Implantable cardioverter-defibrillator lead performance. Circulation 2008;117:2721-3.
12. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 2003;14:38-43.
13. Maloney JD, Hayes DL, Timmis GC. Report of the policy conference of NASPE on device/lead performance and the development of a postmarket surveillance database. The writing committee. Pacing Clin Electrophysiol 1993;16:1945-52.
14. Maisel WH. Transvenous implantable cardioverter-defibrillator leads: the weakest link. Circulation 2007;115:2461-3.
15. Kenigsberg DN, Mirchandani S, Dover AN, Kowalski M, Wood MA, Shepard RK et al. Sensing failure associated with the Medtronic Sprint Fidelis defibrillator lead. J Cardiovasc Electrophysiol 2008;19:270-4.
16. Urgent medical device information: Sprint Fidelis lead patient management recommendations. Minneapolis: Medtronic; 2007. http://www.medtronic.com/ fidelis/physician-letter.html (14 February 2008, date last accessed).
17. Maisel WH. Semper fidelis-consumer protection for patients with implanted medical devices. N Engl J Med 2008;358:985-7.
18. Danik SB, Mansour M, Singh J, Reddy VY, Ellinor PT, Milan D et al. Increased incidence of subacute lead perforation noted with one implantable cardioverterdefibrillator. Heart Rhythm 2007;4:439-42.
19. Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S et al. Necessity for surgical revision of defibrillator leads implanted long-term. Causes and management. Circulation 2008;117:2727-33.
20. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115:2474-80.
21. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K et al. Detection and management of an implantable cardioverter defibrillator lead failure. J Am Coll Cardiol 2003;41:73-80.
22. Luria D, Glikson M, Brady PA, Lexvold NY, Rasmussen MJ, Hodge DO et al. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol 2001;87:901-4.
23. Küpper B, Yee R, O'Hara G, Simpson CS, Della Bella P, Workel M et al. Do small (6.6Fr) active and passive fixation defibrillator leads perform as well as larger sized leads? A multi-centre analysis. Europace 2008;9:657-61.
24. Epstein AE, Kay N, Plumb VJ, Dailey SM, Anderson PG. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 1998;98:1517-24.
25. Auricchio A, Prinzen FW. Cardiac resynchronization therapy: the more pacing sites, the better the outcome? J Am Coll Cardiol 2008;51:1463-5.
26. Jones GK, Bardy GH, Kudenchuk PJ. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J 1995;130:327- 33.
27. Gallik DM, Ben Zur UM, Gross JN, Furman S. Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 1996;19:1089-94.
28. Roelke M, O'Nunain SS, Osswald S, Garan H, Harthorne JW, Ruskin JN. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18:973-9.
29. Gunderson BD, Patel AS, Bounds CA, Shepard RK, Wood MA, Ellenbogen KA. An algorithm to predict implantable cardioverter-defibrillator lead failure. J Am Coll Cardiol 2004;44:1898-902.
30. Metha D, Nayak HE, Singson M, Chao S, Pe E, Camunas JL et al. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol 1998;21:1893-900.
31. Renzulli A, Vitale N, D'Onofrio A, Cotrufo M. Implantable cardioverter defibrillator malfunction due to transvenous lead insulation break. Pacing Clin Electrophysiol 1994;17:245-6.
32. Kitamura S, Satomi K, Kurita T, Shimizu W, Suyama K, Aihara N et al. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J 2006;70:273-7.
33. Epstein AE, Plumb VJ, Kirk KA, Kay GN. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: implications for battery longevity and margin of safety. J Interv Card Electrophysiol 1997;1:131-4.
34. Schwartzman D, Callans DJ, Gottlieb CD, Heo J, Marchlinski FE. Early postoperative rise in defibrillation threshold in patients with nonthoracotomy defibrillation lead systems: attenuation with biphasic shock waveforms. J Cardiovasc Electrophysiol 1996;7:483-93.
35. Gupta A, Zegel HG, Dravid VS, Nierenberg SJ, Freiman DB. Value of radiography in diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. Am J Roentg 1997;168:105-8.
36. Drucker EA, Brooks R, Garan H, Sweeney MO, Ruskin JM, McGovern BA et al. Malfunction of implantable cardioverter defibrillators placed by a non-thoracotomy approach: frequency of malfunction and value of chest radiography in determining cause. Am J Roentg 1995;165:275-9.
37. Antonelli D, Rosenfeld T, Freedberg NA, Palma E, Gross JN, Furman S. Insulation lead failure: is it a matter of insulation coating, venous approach, or both? Pacing Clin Electrophysiol 1998;21:418-21.
38. Hayes DL, Graham KJ, Irwin M, Vidaillet H, Disler G, Sweesy M et al. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 1995;18:999-1004.
39. Vollmann D, Erdogan A, Himmrich E, Neuzner J, Becker D, Unterberg-Buchwald C et al. Patients Alert™ to detect ICD lead failure: efficacy, limitations, and implications for future algorithms. Europace 2006;8:371-6.
40. Bracke FALE, Meijer A, vanGelder LM. Malfunction of endocardial defibrillator leads and lead extraction: where do they meet. Europace 2002;4:19-24.
41. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM et al. Heart Rhythm Society; European Heart Rhythm Association; American College of Cardiology; American Heart Association; European Society of Cardiology; Heart Failure Association of ESC; Heart Failure Society of America. HRS/ EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008;5:907-25.